Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Mar Drugs
2023 Jan 23;212:. doi: 10.3390/md21020078.
Show Gene links
Show Anatomy links
Multiple Effects of Echinochrome A on Selected Ion Channels Implicated in Skin Physiology.
Kim SE
,
Chung EDS
,
Vasileva EA
,
Mishchenko NP
,
Fedoreyev SA
,
Stonik VA
,
Kim HK
,
Nam JH
,
Kim SJ
.
???displayArticle.abstract???
Echinochrome A (Ech A), a naphthoquinoid pigment from sea urchins, is known to have anti-inflammatory and analgesic effects that have been suggested to be mediated by antioxidant activity and intracellular signaling modulation. In addition to these mechanisms, the ion channels in keratinocytes, immune cells, and nociceptive neurons may be the target for the pharmacological effects. Here, using the patch clamp technique, we investigated the effects of Ech A on the Ca2+-permeable TRPV3, TRPV1 and Orai1 channels and the two-pore domain K+ (K2P) channels (TREK/TRAAK, TASK-1, and TRESK) overexpressed in HEK 293 cells. Ech A inhibited both the TRPV3 and Orai1 currents, with IC50 levels of 2.1 and 2.4 μM, respectively. The capsaicin-activated TRPV1 current was slightly augmented by Ech A. Ech A alone did not change the amplitude of the TREK-2 current (ITREK2), but pretreatments with Ech A markedly facilitated ITREK2 activation by 2-APB, arachidonic acid (AA), and acidic extracellular pH (pHe). Similar facilitation effects of Ech A on TREK-1 and TRAAK were observed when they were stimulated with 2-APB and AA, respectively. On the contrary, Ech A did not affect the TRESK and TASK-1 currents. Interestingly, the ITREK2 maximally activated by the combined application of 2-APB and Ech A was not inhibited by norfluoxetine but was still completely inhibited by ruthenium red. The selective loss of sensitivity to norfluoxetine suggested an altered molecular conformation of TREK-2 by Ech A. We conclude that the Ech A-induced inhibition of the Ca2+-permeable cation channels and the facilitation of the TREK/TRAAK K2P channels may underlie the analgesic and anti-inflammatory effects of Ech A.
Acosta,
TREK2 expressed selectively in IB4-binding C-fiber nociceptors hyperpolarizes their membrane potentials and limits spontaneous pain.
2014, Pubmed
Acosta,
TREK2 expressed selectively in IB4-binding C-fiber nociceptors hyperpolarizes their membrane potentials and limits spontaneous pain.
2014,
Pubmed
Alloui,
TREK-1, a K+ channel involved in polymodal pain perception.
2006,
Pubmed
Artyukov,
Marine Polyhydroxynaphthoquinone, Echinochrome A: Prevention of Atherosclerotic Inflammation and Probable Molecular Targets.
2020,
Pubmed
,
Echinobase
Bajaj,
Contributions of natural products to ion channel pharmacology.
2020,
Pubmed
Beltrán,
2-Aminoethoxydiphenyl borate activates the mechanically gated human KCNK channels KCNK 2 (TREK-1), KCNK 4 (TRAAK), and KCNK 10 (TREK-2).
2013,
Pubmed
Benarroch,
Ion channels in nociceptors: recent developments.
2015,
Pubmed
Bennett,
Painful and painless channelopathies.
2014,
Pubmed
Blaydon,
Defective channels lead to an impaired skin barrier.
2014,
Pubmed
Cheng,
TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formation.
2010,
Pubmed
Choi,
The novel high-frequency variant of TRPV3 p.A628T in East Asians showing faster sensitization in response to chemical agonists.
2019,
Pubmed
Choi,
Higher expression of KCNK10 (TREK-2) K+ channels and their functional upregulation by lipopolysaccharide treatment in mouse peritoneal B1a cells.
2021,
Pubmed
Das,
An introduction to pain pathways and pain "targets".
2015,
Pubmed
Djillani,
Role of TREK-1 in Health and Disease, Focus on the Central Nervous System.
2019,
Pubmed
Dong,
K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac.
2015,
Pubmed
Egorov,
[Histochrome, a new antioxidant, in the treatment of ocular diseases].
1999,
Pubmed
Feske,
Calcium signalling in lymphocyte activation and disease.
2007,
Pubmed
Gada,
Two-pore domain potassium channels: emerging targets for novel analgesic drugs: IUPHAR Review 26.
2019,
Pubmed
Han,
A plant-derived TRPV3 inhibitor suppresses pain and itch.
2021,
Pubmed
He,
A gain-of-function mutation in TRPV3 causes focal palmoplantar keratoderma in a Chinese family.
2015,
Pubmed
Hoth,
Depletion of intracellular calcium stores activates a calcium current in mast cells.
1992,
Pubmed
Imbrici,
Ion Channels in Drug Discovery and Safety Pharmacology.
2018,
Pubmed
Ingólfsson,
Phytochemicals perturb membranes and promiscuously alter protein function.
2014,
Pubmed
Jeong,
Echinochrome A protects mitochondrial function in cardiomyocytes against cardiotoxic drugs.
2014,
Pubmed
,
Echinobase
Kang,
Expression of thermosensitive two-pore domain K+ channels in human keratinocytes cell line HaCaT cells.
2007,
Pubmed
Kang,
TREK-2 (K2P10.1) and TRESK (K2P18.1) are major background K+ channels in dorsal root ganglion neurons.
2006,
Pubmed
Kanitakis,
Anatomy, histology and immunohistochemistry of normal human skin.
2002,
Pubmed
Kennard,
Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine.
2005,
Pubmed
Kim,
Molecular Targets of Phytochemicals for Skin Inflammation.
2018,
Pubmed
Kim,
Multifaceted Clinical Effects of Echinochrome.
2021,
Pubmed
,
Echinobase
Lee,
Skin protective effect of guava leaves against UV-induced melanogenesis via inhibition of ORAI1 channel and tyrosinase activity.
2016,
Pubmed
Lin,
Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome.
2012,
Pubmed
Liu,
Exploiting the Diversity of Ion Channels: Modulation of Ion Channels for Therapeutic Indications.
2019,
Pubmed
Liu,
Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonine.
2021,
Pubmed
Lolicato,
K2P2.1 (TREK-1)-activator complexes reveal a cryptic selectivity filter binding site.
2017,
Pubmed
Majtan,
Natural Products and Skin Diseases.
2021,
Pubmed
Mathie,
Pharmacological Approaches to Studying Potassium Channels.
2021,
Pubmed
Mauro,
Keratinocyte K+ channels mediate Ca2+-induced differentiation.
1997,
Pubmed
McCoull,
A "Target Class" Screen to Identify Activators of Two-Pore Domain Potassium (K2P) Channels.
2021,
Pubmed
Mishchenko,
Isolation and Structure Determination of Echinochrome A Oxidative Degradation Products.
2020,
Pubmed
,
Echinobase
Moqrich,
Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin.
2005,
Pubmed
Noël,
The mechano-activated K+ channels TRAAK and TREK-1 control both warm and cold perception.
2009,
Pubmed
Oh,
Echinochrome A Reduces Colitis in Mice and Induces In Vitro Generation of Regulatory Immune Cells.
2019,
Pubmed
,
Echinobase
Park,
Echinochrome A Treatment Alleviates Fibrosis and Inflammation in Bleomycin-Induced Scleroderma.
2021,
Pubmed
,
Echinobase
Peier,
A heat-sensitive TRP channel expressed in keratinocytes.
2002,
Pubmed
Pope,
The Polysite Pharmacology of TREK K2P Channels.
2021,
Pubmed
Pope,
Polynuclear Ruthenium Amines Inhibit K2P Channels via a "Finger in the Dam" Mechanism.
2020,
Pubmed
Proks,
Norfluoxetine inhibits TREK-2 K2P channels by multiple mechanisms including state-independent effects on the selectivity filter gate.
2021,
Pubmed
Sadek,
Echinochrome pigment extracted from sea urchin suppress the bacterial activity, inflammation, nociception, and oxidative stress resulted in the inhibition of renal injury in septic rats.
2022,
Pubmed
,
Echinobase
Sandoz,
Extracellular acidification exerts opposite actions on TREK1 and TREK2 potassium channels via a single conserved histidine residue.
2009,
Pubmed
Sayed,
Echinochrome pigment as novel therapeutic agent against experimentally - induced gastric ulcer in rats.
2018,
Pubmed
,
Echinobase
Schewe,
A pharmacological master key mechanism that unlocks the selectivity filter gate in K+ channels.
2019,
Pubmed
Seol,
Echinochrome A Protects against Ultraviolet B-induced Photoaging by Lowering Collagen Degradation and Inflammatory Cell Infiltration in Hairless Mice.
2021,
Pubmed
Shin,
Inhibition of Ca2+-release-activated Ca2+ channel (CRAC) and K+ channels by curcumin in Jurkat-T cells.
2011,
Pubmed
Smith,
TRPV3 is a temperature-sensitive vanilloid receptor-like protein.
2002,
Pubmed
Steinhoff,
A TR(I)P to pruritus research: role of TRPV3 in inflammation and itch.
2009,
Pubmed
Takei,
Role of STIM1-Orai1 system in intra-cellular calcium elevation induced by ATP in cultured human keratinocytes.
2016,
Pubmed
Vaeth,
CRAC Channels and Calcium Signaling in T Cell-Mediated Immunity.
2020,
Pubmed
Vandenberghe,
ORAI1 calcium channel orchestrates skin homeostasis.
2013,
Pubmed
Varga,
Ion channels in T lymphocytes: an update on facts, mechanisms and therapeutic targeting in autoimmune diseases.
2010,
Pubmed
Wang,
The Ca2+-Permeable Cation Transient Receptor Potential TRPV3 Channel: An Emerging Pivotal Target for Itch and Skin Diseases.
2017,
Pubmed
Woo,
Triple arginine residues in the proximal C-terminus of TREK K+ channels are critical for biphasic regulation by phosphatidylinositol 4,5-bisphosphate.
2019,
Pubmed
Wulff,
Potassium channels as therapeutic targets for autoimmune disorders.
2003,
Pubmed
Xu,
TRPV3 is a calcium-permeable temperature-sensitive cation channel.
2002,
Pubmed
Yan,
Calcium release-activated calcium modulator 1 as a therapeutic target in allergic skin diseases.
2019,
Pubmed
Yun,
Echinochrome A Treatment Alleviates Atopic Dermatitis-like Skin Lesions in NC/Nga Mice via IL-4 and IL-13 Suppression.
2021,
Pubmed
,
Echinobase
Zheng,
Identification of the large-conductance background K+ channel in mouse B cells as TREK-2.
2009,
Pubmed
Şterbuleac,
Molecular determinants of chemical modulation of two-pore domain potassium channels.
2019,
Pubmed